About the Company
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $FLXN News
Why Flexion Therapeutics (FLXN) Stock Is Plummeting in After-Hours Trading Today
Shares of Flexion Therapeutics (FLXN) plunged in after-hours trading Wednesday after the company announced the FDA placed a clinical hold on a Phase 2b trial of the company's osteoarthritis treatment.
Flexion Therapeutics
NOTE: All lobbying expenditures on this page come from the Senate Office of Public Records. Data for the most recent year was downloaded on March 19, 2019. Feel free to distribute or cite this ...
Here's Why You Should Add Pacira (PCRX) Stock to Your Portfolio
Product Acquisitions Through Strategic Collaborations, a Positive: In April 2019, Pacira acquired the privately held company, MyoScience, Inc., following ... of Flexion Therapeutics for $8.50 ...
Why Soleno Therapeutics Stock Is Skyrocketing Today
The clinical-stage biotech company received great news from the FDA.
Stoke Therapeutics CFO Stephen Tulipano Resigns; Thomas Leggett Named Replacement
Stoke Therapeutics, Inc. (STOK) on Monday said its Chief Financial Officer Stephen Tulipano is stepping down with effect from May 7.
PFIZER INC's Net Worth
PFIZER INC has an estimated net worth of $2.44 Billion. This is based on reported shares across multiple companies, which include BioAtla, Inc., Viatris Inc, Cerevel Therapeutics Holdings, Inc ...
Design Therapeutics Inc DSGN
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
RNAZ TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc., a ribonucleic acid (RNA) oncology company, focuses on the development and commercialization of drugs and diagnostics for treating and identifying various cancers.
JSPR Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company’s lead product ...
Outlook Therapeutics, Inc. (OTLK)
ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of ...
Revance Therapeutics, Inc. (NASDAQ:RVNC) is favoured by institutional owners who hold 63% of the company
Institutions' substantial holdings in Revance Therapeutics implies that they have ... recently Every investor in Revance Therapeutics, Inc. (NASDAQ:RVNC) should be aware of the most powerful ...
Loading the latest forecasts...